Acadia Pharmaceuticals



Ebitda Changement Date
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Corcept Therapeutics USD 25.54M 21.37M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
Eisai JPY 37.6B 13.2B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Incyte USD 320.2M 128.19M 2024-12
Intra Cellular Therapies USD -29088000 9.62M 2024-12
J&J USD 6.12B 1.51B 2024-12
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Prothena USD -64676000 1.61M 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Acadia Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.